Huntington National Bank’s Harmony Biosciences HRMY Stock Holding History

Huntington National Bank’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$924	Sell	33 -7	-18%	-$230	﹤0.01%	2379
2025 Q4	$1.5K	Sell	40 -81	-67%	-$2.66K	﹤0.01%	2233
2025 Q3	$3.33K	Hold	121	–	–	﹤0.01%	2102
2025 Q2	$3.82K	Buy	121 +75	+163%	+$2.41K	﹤0.01%	2075
2025 Q1	$1.53K	Sell	46 -77	-63%	-$2.76K	﹤0.01%	2287
2024 Q4	$4.23K	Buy	123 +40	+48%	+$1.37K	﹤0.01%	2050
2024 Q3	$3.32K	Hold	83	–	–	﹤0.01%	2106
2024 Q2	$2.5K	Buy	83 +6	+8%	+$180	﹤0.01%	2101
2024 Q1	$2.59K	Hold	77	–	–	﹤0.01%	2078
2023 Q4	$2.49K	Sell	77 -4	-5%	-$112	﹤0.01%	2037
2023 Q3	$2.65K	Buy	+81	New	+$2.81K	﹤0.01%	1987
2023 Q2	–	Sell	-655	Closed	-$21.4K	–	3801
2023 Q1	$21.4K	Buy	655 +257	+65%	+$11.7K	﹤0.01%	1295
2022 Q4	$21.9K	Hold	398	–	–	﹤0.01%	1254
2022 Q3	$18K	Buy	+398	New	+$19.4K	﹤0.01%	1326

Other funds holding HRMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Huntington National Bank's HRMY Position: Q1 2026 in Review

Huntington National Bank reduced its Harmony Biosciences (HRMY) stake by 18% in Q1 2026, selling an estimated $230 and leaving 33 shares worth $924. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

Huntington National Bank first reported a position in HRMY in Q3 2022 and has held it in 14 quarters since. The position peaked at $21.9K in Q4 2022. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

Huntington National Bank held 33 shares of Harmony Biosciences worth $924 as of Q1 2026.
Huntington National Bank sold 7 Harmony Biosciences shares in Q1 2026, an estimated $230.
Harmony Biosciences made up ﹤0.01% of Huntington National Bank's portfolio in Q1 2026, its #2379 holding.
Huntington National Bank first reported a position in Harmony Biosciences in Q3 2022 and has held it in 14 quarters since.
Huntington National Bank's Harmony Biosciences position peaked at $21.9K in Q4 2022.
309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Huntington National Bank's 13F filing for Q1 2026, filed 15 May 2026.